Shares of Mettler-Toledo International Inc. (NYSE:MTD) have been given an average recommendation of “Hold” by the nine brokerages that are covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating and six have issued a hold rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $673.83.
A number of research firms recently weighed in on MTD. Zacks Investment Research cut Home Bancshares from a “hold” rating to a “sell” rating in a report on Friday, June 7th. Wolfe Research began coverage on Waters in a report on Thursday, May 30th. They set an “underperform” rating for the company. ValuEngine cut Zumiez from a “hold” rating to a “sell” rating in a report on Monday, May 13th. Barclays began coverage on Grocery Outlet in a research note on Monday. They issued an “equal weight” rating and a $32.00 target price for the company. Finally, Bank of America cut Propetro from a “buy” rating to a “neutral” rating in a research note on Tuesday, April 16th.
In other news, CFO Shawn Vadala sold 700 shares of Mettler-Toledo International stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $721.00, for a total value of $504,700.00. Following the completion of the sale, the chief financial officer now directly owns 5,450 shares of the company’s stock, valued at approximately $3,929,450. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider La Guerroniere Marc De sold 4,625 shares of Mettler-Toledo International stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $750.00, for a total value of $3,468,750.00. Following the completion of the sale, the insider now directly owns 16,610 shares of the company’s stock, valued at $12,457,500. The disclosure for this sale can be found here. Insiders sold a total of 48,925 shares of company stock valued at $35,650,928 over the last three months. Insiders own 3.50% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in MTD. Nordea Investment Management AB boosted its position in shares of Mettler-Toledo International by 65.0% in the 4th quarter. Nordea Investment Management AB now owns 37,599 shares of the medical instruments supplier’s stock worth $21,266,000 after purchasing an additional 14,805 shares during the last quarter. Meiji Yasuda Asset Management Co Ltd. bought a new position in shares of Mettler-Toledo International in the 1st quarter worth $253,000. Marshall Wace LLP boosted its position in shares of Mettler-Toledo International by 21,807.4% in the 1st quarter. Marshall Wace LLP now owns 14,897 shares of the medical instruments supplier’s stock worth $10,771,000 after purchasing an additional 14,829 shares during the last quarter. Gulf International Bank UK Ltd boosted its position in shares of Mettler-Toledo International by 11.3% in the 1st quarter. Gulf International Bank UK Ltd now owns 6,337 shares of the medical instruments supplier’s stock worth $4,581,000 after purchasing an additional 641 shares during the last quarter. Finally, Tiemann Investment Advisors LLC bought a new position in shares of Mettler-Toledo International in the 1st quarter worth $217,000. 95.29% of the stock is owned by institutional investors.
MTD stock traded up $1.69 during midday trading on Friday, reaching $823.54. 674 shares of the company’s stock traded hands, compared to its average volume of 139,238. The business has a 50-day moving average of $808.81. Mettler-Toledo International has a 1-year low of $500.74 and a 1-year high of $873.51. The stock has a market cap of $20.47 billion, a P/E ratio of 40.59, a price-to-earnings-growth ratio of 2.65 and a beta of 1.33. The company has a current ratio of 1.37, a quick ratio of 0.97 and a debt-to-equity ratio of 1.80.
Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.06 by $0.04. Mettler-Toledo International had a return on equity of 95.67% and a net margin of 17.98%. The firm had revenue of $679.50 million during the quarter, compared to analysts’ expectations of $673.55 million. During the same period last year, the firm posted $3.74 EPS. The business’s revenue was up 2.8% on a year-over-year basis. On average, sell-side analysts anticipate that Mettler-Toledo International will post 22.7 earnings per share for the current fiscal year.
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.
Further Reading: Federal Reserve
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.